ROMANO, ELOISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.800
EU - Europa 3.099
AS - Asia 2.660
SA - Sud America 474
AF - Africa 72
OC - Oceania 46
Continente sconosciuto - Info sul continente non disponibili 2
Totale 11.153
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.745
RU - Federazione Russa 1.280
SG - Singapore 748
CN - Cina 714
PL - Polonia 518
HK - Hong Kong 425
BR - Brasile 388
IT - Italia 349
KR - Corea 275
IE - Irlanda 252
SE - Svezia 208
VN - Vietnam 172
FI - Finlandia 153
IN - India 120
DE - Germania 110
GB - Regno Unito 62
FR - Francia 52
ID - Indonesia 49
JO - Giordania 47
AU - Australia 44
AR - Argentina 34
CA - Canada 32
ES - Italia 24
MX - Messico 20
ZA - Sudafrica 20
IQ - Iraq 19
NL - Olanda 18
EC - Ecuador 16
UA - Ucraina 16
JP - Giappone 14
BE - Belgio 13
CH - Svizzera 13
MA - Marocco 12
TR - Turchia 12
BD - Bangladesh 11
CI - Costa d'Avorio 10
CO - Colombia 9
UY - Uruguay 8
PH - Filippine 7
UZ - Uzbekistan 7
VE - Venezuela 7
AZ - Azerbaigian 6
BJ - Benin 6
AE - Emirati Arabi Uniti 5
BG - Bulgaria 5
DK - Danimarca 5
KE - Kenya 5
KZ - Kazakistan 5
PK - Pakistan 5
TN - Tunisia 5
CL - Cile 4
LT - Lituania 4
LU - Lussemburgo 4
NP - Nepal 4
PE - Perù 4
PY - Paraguay 4
SA - Arabia Saudita 4
SN - Senegal 4
AT - Austria 3
CG - Congo 3
EG - Egitto 3
CZ - Repubblica Ceca 2
DZ - Algeria 2
KG - Kirghizistan 2
RO - Romania 2
TH - Thailandia 2
BH - Bahrain 1
CR - Costa Rica 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GR - Grecia 1
IR - Iran 1
JM - Giamaica 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MD - Moldavia 1
MK - Macedonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
TO - Tonga 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 11.153
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.086
Singapore 569
Ashburn 550
Warsaw 515
Fairfield 433
Hong Kong 371
Seoul 273
Dublin 247
Chandler 244
Hefei 238
Woodbridge 208
Seattle 178
Houston 166
Cambridge 155
Beijing 145
Wilmington 127
Florence 117
San Jose 110
Ann Arbor 79
Helsinki 75
Los Angeles 75
Dallas 72
Munich 72
Lawrence 71
Altamura 69
Ho Chi Minh City 64
Princeton 57
Mumbai 55
Moscow 53
New York 50
Boston 45
Buffalo 43
Melbourne 39
Jakarta 36
Paris 36
São Paulo 36
Shanghai 35
Kent 34
Hanoi 33
The Dalles 33
Turku 32
San Diego 26
Redondo Beach 23
Boardman 22
Chicago 21
Clifton 20
Lappeenranta 20
Medford 19
Fiesole 17
Milan 17
Pune 17
Dong Ket 14
Rio de Janeiro 14
Falls Church 13
Johannesburg 13
Montreal 13
Tianjin 13
Toronto 13
Atlanta 12
Bengaluru 12
Guangzhou 12
Jacksonville 12
Baghdad 11
Chennai 11
Denver 11
Hillsboro 11
London 11
Abidjan 10
Phoenix 10
West Jordan 10
Orem 9
Tokyo 9
Brooklyn 8
Manchester 8
Mexico City 8
Porto Alegre 8
Brasília 7
Brussels 7
Castelliri 7
Poplar 7
San Francisco 7
Sesto Fiorentino 7
Shenzhen 7
Yubileyny 7
Andover 6
Belo Horizonte 6
Bern 6
Biên Hòa 6
Casablanca 6
Cotonou 6
Haiphong 6
Izmir 6
Manila 6
Perugia 6
Stockholm 6
Tashkent 6
Baku 5
Buenos Aires 5
Caxias do Sul 5
Fortaleza 5
Totale 7.552
Salva come PNG Salva come JPEG
Nome #
Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis 312
Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis 306
Decreased expression of the endothelial cell-derived factor EGFL7 in systemic sclerosis: potential contribution to impaired angiogenesis and vasculogenesis 247
Clinical, instrumental, serological and histological findings suggest that hemophilia B may be less severe than hemophilia A 234
Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis 218
Agonistic anti-human Fas monoclonal antibody induces fibroblast-like synoviocyte apoptosis in haemophilic arthropathy: potential therapeutic implications 207
Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells 202
Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis 194
Angiotensin II type 2 receptor (AT2R) as a novel modulator of inflammation in rheumatoid arthritis synovium 187
TNF-α/TNF-R System May Represent a Crucial Mediator of Proliferative Synovitis in Hemophilia A 181
Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro 180
Decrease of LL-37 in systemic sclerosis: a new marker for interstitial lung disease? 179
A two-step immunomagnetic microbead-based method for the isolation of human primary skin telocytes/CD34+ stromal cells 179
Systemic Sclerosis Serum Steers the Differentiation of Adipose-Derived Stem Cells Toward Profibrotic Myofibroblasts: Pathophysiologic Implications 171
Enthesopathy and involvement of synovio-entheseal complex in systemic sclerosis: an ultrasound pilot study 169
Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis 167
The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis 165
Vascular biomarkers and correlation with peripheral vasculopathy in systemic sclerosis 165
Slit2/Robo4 axis may contribute to endothelial cell dysfunction and angiogenesis disturbance in systemic sclerosis 162
POS0613 THE ROLE OF MICROBIOTA IN DIFFERENT DISEASE STAGES OF SYSTEMIC SCLEROSIS: A POSSIBLE IMPACT IN GASTROINTESTINAL TRACT DISEASE ACTIVITY? 161
Evidence for a Derangement of the Microvascular System in Patients with a Very Early Diagnosis of Systemic Sclerosis 161
The differential crosstalk of the skin-gut microbiome axis as a new emerging actor in systemic sclerosis 160
Neuropeptides activate TRPV1 in rheumatoid arthritis fibroblast-like synoviocytes and foster IL-6 and IL-8 production. 159
A candidate gene study reveals association between a variant of the SRp55 splicing factor gene and systemic sclerosis 156
Lymphatic Endothelial-to-Myofibroblast Transition: A Potential New Mechanism Underlying Skin Fibrosis in Systemic Sclerosis 155
Extracellular Lactic Acidosis of the Tumor Microenvironment Drives Adipocyte-to-Myofibroblast Transition Fueling the Generation of Cancer-Associated Fibroblasts 151
Blockade of Sialylation with Decrease in Polysialic Acid Levels Counteracts Transforming Growth Factor β1-Induced Skin Fibroblast-to-Myofibroblast Transition 151
Disease Activity Improvement in Rheumatoid Arthritis Treated with Tumor Necrosis Factor-α Inhibitors Correlates with Increased Soluble Fas Levels. 151
Extracellular lactic acidosis drives reprogramming of human subcutaneous adipocytes toward pathogenic myofibroblasts 150
Differential expression of junctional adhesion molecules in different stages of systemic sclerosis 147
THE CROSSTALK OF THE SKIN-ORAL-GUT MICROBIOME AXIS IN LIMITED AND DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS 145
Circulating Neurovascular Guidance Molecules and Their Relationship with Peripheral Microvascular Impairment in Systemic Sclerosis 144
Decreased circulating lymphatic endothelial progenitor cells in digital ulcer-complicated systemic sclerosis 142
Increased plasma levels of the VEGF165b splice variant are associated with the severity of nailfold capillary loss in systemic sclerosis 141
Systemic Sclerosis Serum Significantly Impairs the Multi-Step Lymphangiogenic Process: in Vitro Evidence 140
Decreased Serum Levels of SIRT1 and SIRT3 Correlate with Severity of Skin and Lung Fibrosis and Peripheral Microvasculopathy in Systemic Sclerosis 140
The Soluble Guanylate Cyclase Stimulator BAY 41-2272 Attenuates Transforming Growth Factor β1-Induced Myofibroblast Differentiation of Human Corneal Keratocytes 139
Adipose-derived stem cells: Pathophysiologic implications vs therapeutic potential in systemic sclerosis 139
STIMULATION OF SOLUBLE GUANYLATE CYCLASE (sGC) FOSTERS ANGIOGENESIS AND BLUNTS ENDOTHELIAL-TO-MESENCHYMAL TRANSITION (EndoMT) OF SYSTEMIC SCLEROSIS (SSc) DERMAL MICROVASCULAR ENDOTHELIAL CELLS 139
Autoantibodies as putative biomarkers and triggers of cell dysfunctions in systemic sclerosis 136
Immunohistochemical and ultrastructural identification of telocytes in the lamina propria of human vaginal mucosa 135
DECIPHERING THE GUT MICROBIOTA OF VERY EARLY SYSTEMIC SCLEROSIS (VEDOSS) PATIENTS: A TAXONOMIC AND FUNCTIONAL CHARACTERIZATION 135
Current Trends in Vascular Biomarkers for Systemic Sclerosis: A Narrative Review 135
The contribution of mesenchymal transitions to the pathogenesis of systemic sclerosis 134
Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage 134
Pharmacological Stimulation of Soluble Guanylate Cyclase Counteracts the Profibrotic Activation of Human Conjunctival Fibroblasts 131
Soluble guanylate cyclase stimulation fosters angiogenesis and blunts myofibroblast-like features of systemic sclerosis endothelial cells 131
Advances in Systemic Sclerosis: From Pathogenetic Pathways toward Novel Therapeutic Targets 131
Skin telocyte secretome as conditioned medium prevents profibrotic differentiation of skin fibroblasts into myofibroblasts 130
Scleroderma-like Impairment in the Network of Telocytes/CD34+ Stromal Cells in the Experimental Mouse Model of Bleomycin-Induced Dermal Fibrosis 129
Increased Circulating Soluble Junctional Adhesion Molecules in Systemic Sclerosis: Association with Peripheral Microvascular Impairment 127
Soluble guanylate cyclase stimulation fosters angiogenesis and blunts myofibroblast-like features of scleroderma endothelial cells 124
Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis 123
Evidence for caveolin-1 as a new susceptibility gene regulating tissue fibrosis in systemic sclerosis. 123
FAS/FASL and TF/FVII Levels In Rheumatoid Arthritis Patients Treated With TNF Antagonists 123
Oral lactobacillus species in systemic sclerosis 123
Progressive loss of lymphatic vessels in skin of patients with systemic sclerosis 122
Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis 122
POS1593-HPR GASTROINTESTINAL INVOLVEMENT IS ALREADY REPORTED IN AN ITALIAN VEDOSS COHORT: RESULTS FROM A RHEUMATOLOGICAL NURSE ASSESSMENT 120
Bosentan blocks the antiangiogenic effects of sera from systemic sclerosis patients: an in vitro study 119
A new avenue in the pathogenesis of systemic sclerosis: the molecular interface between the endothelial and the nervous systems 119
Decreased expression of the endothelial cell-derived factor EGFL7 contributes to impaired angiogenesis and vasculogenesis in systemic sclerosis 118
Recent Insights into Cellular and Molecular Mechanisms of Defective Angiogenesis in Systemic Sclerosis 115
The contribution of endothelial cells to tissue fibrosis 115
ORAL MICROBIOME IN RHEUMATIC DISEASES.WHAT INVOLVEMENT? 112
The Role of Pro-fibrotic Myofibroblasts in Systemic Sclerosis: From Origin to Therapeutic Targeting 109
The contribution of epigenetics to the pathogenesis and gender dimorphism of systemic sclerosis: a comprehensive overview 106
Impairment in the telocyte/CD34+ stromal cell network in human rheumatoid arthritis synovium 104
Stiff Skin Syndrome 100
Blockade of sialylation with decrease in polysialic acid levels counteracts transforming growth factor β1-induced skin fibroblast-to-myofibroblast transition 99
Gut microbiota in very early systemic sclerosis: the first case-control taxonomic and functional characterisation highlighting an altered butyric acid profile 93
Increased circulating levels of interleukin 33 in systemic sclerosis correlate with early disease stage and microvascular involvement 92
The authors' reply 92
Skin Telocyte Secretome as Conditioned Medium Prevents Profibrotic Differentiation of Skin Fibroblasts into Myofibroblasts 89
New Insights into Profibrotic Myofibroblast Formation in Systemic Sclerosis: When the Vascular Wall Becomes the Enemy 85
Soluble α-Klotho protects dermal microvascular endothelial cells against endothelial-to-mesenchymal transition 74
The genetics of systemic sclerosis: an update. 72
Pathophysiologic implications and therapeutic potentials of telocytes in multiorgan fibrosis 70
Soluble α-Klotho protects dermal microvascular endothelial cells against endothelial-to-myofibroblast transition 59
Stimulation of soluble guanylate cyclase: A novel approach to treat conjunctival fibrosis 57
Totale 11.363
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.887
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.887
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021407 0 0 0 0 0 0 63 50 83 125 39 47
2021/2022361 14 10 19 12 23 33 7 12 34 23 51 123
2022/20231.132 104 235 43 79 56 196 163 49 125 11 37 34
2023/2024587 14 60 85 31 46 81 36 112 10 29 40 43
2024/20253.651 119 387 271 577 1.023 340 133 250 114 96 154 187
2025/20263.353 488 606 575 665 592 203 224 0 0 0 0 0
Totale 11.363